Literature DB >> 4735938

Hypertrophic subaortic stenosis. Clinical and hemodynamic effects of long-term propranolol therapy.

R E Stenson, M D Flamm, D C Harrison, E W Hancock.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4735938     DOI: 10.1016/0002-9149(73)90012-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  6 in total

Review 1.  Hypertrophic cardiomyopathy: diagnosis, risk stratification and treatment.

Authors:  Daniel L Jacoby; Eugene C DePasquale; William J McKenna
Journal:  CMAJ       Date:  2012-10-29       Impact factor: 8.262

Review 2.  Nonobstructive and obstructive hypertrophic cardiomyopathies.

Authors:  J Ross; R Shabetai; G Curtis; R L Engler; D L Costello; M M LeWinter; A D Johnson; C B Higgins; G Gregoratos; J R Utley; R Shabetai
Journal:  West J Med       Date:  1979-04

3.  Treatment of hypertrophic obstructive cardiomyopathy with verapamil.

Authors:  M Kaltenbach; R Hopf; G Kober; W D Bussmann; M Keller; Y Petersen
Journal:  Br Heart J       Date:  1979-07

Review 4.  Hypertrophic cardiomyopathy: an updated review on diagnosis, prognosis, and treatment.

Authors:  George Makavos; Chris Κairis; Maria-Eirini Tselegkidi; Theodoros Karamitsos; Angelos G Rigopoulos; Michel Noutsias; Ignatios Ikonomidis
Journal:  Heart Fail Rev       Date:  2019-07       Impact factor: 4.214

Review 5.  Potential mechanisms of improvement after various treatments for hypertrophic obstructive cardiomyopathy.

Authors:  R D Leachman
Journal:  Tex Heart Inst J       Date:  1995

6.  Effect of disopyramide on left ventricular diastolic function in patients with hypertrophic cardiomyopathy: comparison with diltiazem.

Authors:  T Sumimoto; M Hamada; T Ohtani; M Suzuki; M Abe; H Matsuoka; Y Fujiwara; M Sekiya; K Hiwada
Journal:  Cardiovasc Drugs Ther       Date:  1992-08       Impact factor: 3.727

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.